SYK STRYKER CORP

2026Q2 · CUSIP 863667101 · Sector: Healthcare & Biotech

Normal

Fund flows are within the usual range

Funds that own it

2,215

Institutions that reported holding it to the SEC

Net decrease in holders

Last quarter 2,303 → now 2,215

How unusual is that

Bottom 20%

Stronger than only 1.1% of US stocks

What the filings say, in one paragraph

2,215 funds held SYK at the end of 2026Q2, down 88 from the quarter before. Fund flows are within the usual range — nothing unusual. On the business itself, revenue over the last 12 months was $25.8B(YoY +8.5%), the P/E is 32.4x, return on equity is 15.6%. SYK has had 33 buying rushes in its history, and the price moved +1.9% on average over the six months after (that is the raw price move, not how much it beat the market by). It sits in the Healthcare & Biotech sector.

How many funds owned it, quarter by quarter

Bars = net change in institutional holders, positive (green) or negative (red). Line = total institutional holders.

What happened after each past buying rush 33 times in its history

Quarter of the rush	How unusual then	Price, next 3 months	Price, next 6 months
2025Q4	Top 10%	-10.7%	-13.5%
2025Q2	Top 10%	-4.4%	-4.9%
2025Q1	Top 10%	+0.4%	-1.0%
2024Q4	Top 5%	-2.9%	+2.6%
2024Q3	Top 5%	-6.9%	-1.5%
2024Q1	Top 1% in the market	-0.6%	+2.1%
2023Q4	Top 5%	+0.7%	-4.0%
2023Q2	Top 1% in the market	-2.7%	+0.8%
2023Q1	Top 5%	+5.2%	-1.9%
2022Q4	Top 5%	+9.5%	+8.7%
2022Q1	Top 10%	-12.7%	-4.6%
2021Q4	Top 5%	+3.9%	-10.3%
2021Q2	Top 10%	-0.2%	-0.3%
2021Q1	Top 20%	+5.3%	+4.7%
2020Q4	Top 5%	+1.6%	+3.2%
2020Q2	Top 10%	+10.7%	+23.0%
2019Q4	Top 5%	-34.5%	-18.3%
2019Q3	Top 5%	+3.8%	+9.8%
2019Q1	Top 5%	+13.3%	+18.1%
2018Q4	Top 5%	+4.6%	-1.2%
2018Q3	Top 10%	-8.5%	+9.3%
2018Q2	Top 5%	+5.4%	-1.3%
2018Q1	Top 10%	-0.6%	-1.2%
2017Q4	Top 5%	+0.4%	+8.4%
2017Q2	Top 10%	-2.4%	+6.1%
2017Q1	Top 5%	+3.8%	+10.7%
2016Q4	Top 5%	+4.8%	+7.6%
2016Q2	Top 10%	+3.2%	-2.7%
2016Q1	Top 20%	+10.0%	+3.3%
2015Q1	Top 20%	-0.2%	+8.2%
2014Q4	Top 5%	-2.6%	+2.7%
2014Q1	Top 5%	+7.0%	+1.9%
2013Q4	Top 10%	-1.4%	-3.5%

Show all 33 events

These are the raw price moves, not how much it beat the market by. Compare them against the market over the same months — in a strong bull market almost everything is up.

Show all the numbers (large funds, value held, options…) ▾

Of them, large funds

365

Change in large funds

+21

Total value they hold

$96.7B

Funds buying for the first time

171

Funds that sold out entirely

259

Price change that quarter

-0.1%

Funds holding puts (bearish)

Funds holding calls (bullish)

These are for people who want to dig. Skip them if they do not mean anything to you — the three numbers above are enough.

8,697 institutions have filed for this quarter. 13F permits late filing and a small number arrive in the weeks after the deadline, so the holder counts and changes below may tick up.

Fundamentals

PE (TTM)

32.4

EPS (TTM)

$9.65

EPS YoY

+27.8%

Revenue (TTM)

$25.8B

Revenue YoY

+8.5%

Net margin

14.4%

ROE

15.6%

Debt ratio

50.0%

FCF (TTM)

$4.7B

Dividend (TTM)

$3.48

Quarterly Revenue & EPS

Quarterly figures, revenue up to 10 years back; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time

P/E = close around day 47 after quarter-end ÷ TTM EPS then; this is a consistent valuation date, not the company’s actual filing date; loss quarters hidden

Quarterly free cash flow

Latest quarter $415M (2026-03-31)

FCF = operating cash flow − capex, computed from SEC XBRL; banks/insurers have no standard cash-flow structure and are hidden

As of 2026-06-30 · SEC filings (XBRL)

Email me the next update

2026 Q3 holdings are due 2026-11-16. We will email you when the refreshed lists are live.